Expertise

Granulocyte Colony Stimulating Factor (G-CSF)

CCDRD AG started a multicentric, multinational dose-finding trial with the biotech drug G-CSF. The patients are being recruited in 5 countries in Europe and Asia.

Phase II trial, multinational

Dose-finding study

Non-Hodgkin´s Lymphoma patients